Showing 15 posts of 35 posts found.


Forecasts show branded generics will double in revenue with Asia driving growth

February 13, 2020
Business Services branded drugs, drug patents, patents

Branded generic drugs are expected to grow in global sales by 8% by 2029, but Europe and America will not …


Gilead challenges Government over patents on preventative HIV drug Truvada

August 22, 2019
Research and Development, Sales and Marketing AIDS, CDC, Gilead, HIV, IP, PrEP, Truvada, government, patents

Gilead is challenging the US Government’s patents on PrEP drug Truvada. The Foster City firm has submitted a challenge to …

China urges firms to make generic versions of 34 drugs

June 25, 2019
Research and Development China, NHC, generic drugs, generics, patents, pharma

China’s National Health Commission (NHC) has urged generic drugmakers to pick up the production of 34 drugs that are not …

Gilead accused of ripping off US taxpayers

March 28, 2019
Medical Communications, Sales and Marketing CDC, Gilead, HIV, PrEP, Truvada, US government, patents

Gilead have been accused of ‘ripping off’ US taxpayers after the firm was revealed to have generated $3 billion in …


Repurposed drugs: The Supreme Court deals a blow to patentees

January 31, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Supreme Court, drug repurposing, feature, patents, pharma

Second medical use patents protect the discovery that an existing drug is effective to treat a new condition. But, following …


Allergan and St Regis Mohawk Tribe take patent ruling to Supreme Court

January 28, 2019
Sales and Marketing Allergan, Mohawk, Restasis, St Regis, eye drops, patents

Allergan and the St Regis Mohawk Tribe have asked the Supreme Court to defend a 2017 patent agreement which would …

Fewer patents being filed for novel infectious diseases and AMR diagnostic technologies; US leads, UK follows

October 17, 2018
Research and Development AMR, IP, intellectual property, patents

Fewer patents are being filed for point-of-care diagnostic technologies aimed at tackling infectious diseases and antimicrobial resistance (AMR), according to …


AbbVie suffers knock to Humira patent

May 19, 2017
Medical Communications, Sales and Marketing AbbVie, Humira, patents

Humira is the largest selling pharmaceutical drug in the world. The treatment for rheumatoid arthritis brought in over $16 billion …


In-depth: MSF takes on Pfizer, GSK

May 3, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Doctors Without Borders, GSK, Pfizer, analysis, medicins sans frontieres, patents, pneumonia

Medicins Sans Frontieres (MSF) recently stepped up their campaign to make the pneumonia vaccine more available in developing countries. Appearing …


Federal jury rules in MSD’s favour in Gilead blockbuster hepatitis C drug dispute

March 23, 2016
Medical Communications, Research and Development Gilead, MSD, blockbuster, federal court, federal jury, hit, patents, sales, sales hit, sofosbuvir, sovaldi

Gilead’s dominance of the hepatitis C market is under severe threat after a federal jury ruled in favour of MSD …


Delivering successful new drugs

March 1, 2016
Manufacturing and Production, Sales and Marketing AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Pfizer, patents, pharma

Pharma companies are struggling with challenges specific to their industry. Patents for many drugs, that had created massive amounts of …


US Federal Trade Commission clamps down on pharma ‘pay to delay’ deals

January 14, 2016
Manufacturing and Production, Sales and Marketing Pay to delay, US Supreme Court, antitrust laws, federal trade commission, generic competition, generics, patents, pay for delay

Pharma companies were able to negotiate far fewer so-called ‘pay to delay’ cases as a strategy to stave off generic …

Celgene logo

Celgene settles Revlimid patent dispute

December 23, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Celgene, India, Natco, Revlimid, lenalidomide, patents

Celgene has settled its litigation with Natco Pharma, over the patents for Revlimid, opening the door to increased generic competition …


Patents prompting ‘rebirth’ of innovation in industry

November 13, 2015
Medical Communications innovation, patents, pharma

Seven pharma companies have been rated among the world’s 100 most innovative companies, according to Thomson Reuters.The business intelligence firm …

Prof Paul Workman

Putting off-patent drugs back to work

November 4, 2015
Research and Development, Sales and Marketing Off-Patent Drugs Bill, Professor Paul Workman, The ICR, The ICR London, drug repurposing, patents

Six clinicians here at The Institute of Cancer Research, London, have joined colleagues from across the UK in writing to …

Latest content